MedTrace Logo

Study on the Registration of Coronary Heart Disease Patients Undergoing PCI

NCT02888652 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2019-10-14

No results posted yet for this study

Summary

Study on the registration of coronary heart disease patients undergoing PCI in Chinese's population. Get the incidence of adverse events in these patients after PCI, a clear type of adverse reaction, forms, influencing factors, to establish risk management processes, clinical safety and reasonable treatment, and provide the basis for further research and reference.

Conditions

Interventions

DRUG

antiplatelet agents(Clopidogrel or Ticagrelor)

Clinical physicians according to patients condition to give different antiplatelet agents(Clopidogrel or Ticagrelor).We only observe clinical curative effect.

Sponsors & Collaborators

  • The Third Xiangya Hospital of Central South University

    lead OTHER

Principal Investigators

  • GuoPing Yang, professor · The Third Xiangya Hospital of Central South University

  • Yu Cao, MD · The Third Xiangya Hospital of Central South University

  • Jingle Li, MD · The Third Xiangya Hospital of Central South University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2018-08-31
Completion
2018-10-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02888652 on ClinicalTrials.gov